Skip to main content
Erschienen in: Journal of Gastroenterology 7/2009

01.07.2009 | Original Article—Liver, Pancreas, and Biliary Tract

Nonalcoholic fatty liver is a risk factor for postprandial hyperglycemia, but not for impaired fasting glucose

verfasst von: Tomoko Shiga, Yuriko Moriyoshi, Hikaru Nagahara, Keiko Shiratori

Erschienen in: Journal of Gastroenterology | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The first aim of this study was to elucidate the relationship between impaired glucose tolerance (IGT) and nonalcoholic fatty liver. The second was to make a rule regarding to whom 75-g oral glucose tolerance tests (OGTTs) should be applied to identify subjects with IGT and diabetes mellitus (DM) in the annual check-up at the human dry dock.

Methods

A total of 716 subjects who visited the Department of General Medicine of the International Medical Center of Japan from May 2001 through January 2008 for an annual check-up at the human dry dock were analyzed. We evaluated risk factors related to nonalcoholic fatty liver using multivariate logistic regression analysis and compared the difference of body mass index (BMI) and glucose level at 75-g OGTT at two different time points in subjects whose fatty change had improved or worsened.

Results

Nonalcoholic fatty liver was strongly related to 2-h- and 1-h-post-challenge glucose level (P < 0.0001 and P = 0.018, respectively), but not fasting plasma glucose (FPG) (P = 0.706). The risk factors for IGT were nonalcoholic fatty liver (P < 0.05), low levels of high-density lipoprotein cholesterol (HDL-C) (P = 0.026) and age (P = 0.013). A clearly positive relationship was observed between the difference of BMI and 2-h-post-challenge glucose level among the subjects whose fatty change had improved or worsened (R = 0.6, P = 0.018).

Conclusions

Nonalcoholic fatty liver was clearly related to the 2-h- or 1-h-post-challenge glucose level, but not to FPG, in 75-g OGTT, and this IGT was corrected by body weight reduction in accordance with diminished nonalcoholic fatty liver. Thus, 75-g OGTT should be applied to subjects with nonalcoholic fatty liver to evaluate IGT.
Literatur
1.
Zurück zum Zitat Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullogh AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:413–1419.CrossRef Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullogh AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:413–1419.CrossRef
2.
Zurück zum Zitat Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 1995;22:1714–9.PubMedCrossRef Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 1995;22:1714–9.PubMedCrossRef
3.
Zurück zum Zitat Su C-C, Wang K, Hsia T-L, Chen C-S, Tung T-H. Association of nonalcoholic fatty liver disease with abnormal aminotransferase and postprandial hyperglycemia. J Clin Gastroenterol. 2006;40:551–4.PubMedCrossRef Su C-C, Wang K, Hsia T-L, Chen C-S, Tung T-H. Association of nonalcoholic fatty liver disease with abnormal aminotransferase and postprandial hyperglycemia. J Clin Gastroenterol. 2006;40:551–4.PubMedCrossRef
4.
Zurück zum Zitat Day CP, James O. Steatohepatitis: a tale of “two-hits”. Gastroenterology. 1998;114:842–5.PubMedCrossRef Day CP, James O. Steatohepatitis: a tale of “two-hits”. Gastroenterology. 1998;114:842–5.PubMedCrossRef
6.
Zurück zum Zitat Sargin M, Uygur-Bayramiçli O, Sargin H, Orbay E, Yayla A. Association of nonalcoholic fatty liver disease with insulin resistance. Is OGTT indicated in nonalcoholic fatty liver disease? J Clin Gastroenterol. 2003;37:399–402.PubMedCrossRef Sargin M, Uygur-Bayramiçli O, Sargin H, Orbay E, Yayla A. Association of nonalcoholic fatty liver disease with insulin resistance. Is OGTT indicated in nonalcoholic fatty liver disease? J Clin Gastroenterol. 2003;37:399–402.PubMedCrossRef
7.
Zurück zum Zitat Frilis-Liby I, Aldenborg F, Jerlstad P, Rundström K, Björnsson E. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease. Scand J Gastroenterol. 2004;9:864–9.CrossRef Frilis-Liby I, Aldenborg F, Jerlstad P, Rundström K, Björnsson E. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease. Scand J Gastroenterol. 2004;9:864–9.CrossRef
8.
Zurück zum Zitat National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–57. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–57.
9.
Zurück zum Zitat Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–97. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–97.
10.
Zurück zum Zitat Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med. 1998;15:539–53. for the WHO Consultation.PubMedCrossRef Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med. 1998;15:539–53. for the WHO Consultation.PubMedCrossRef
11.
Zurück zum Zitat Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55:65–85.PubMedCrossRef Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55:65–85.PubMedCrossRef
12.
Zurück zum Zitat Kawamori R. The role of the liver on post-prandial glycaemia-emphasis on hepatic glucose uptake. Int J Clin Prat Suppl. 2000;112:19–22. Kawamori R. The role of the liver on post-prandial glycaemia-emphasis on hepatic glucose uptake. Int J Clin Prat Suppl. 2000;112:19–22.
13.
Zurück zum Zitat Mueller MJ, Boeker K, Selberg O. Metabolism of energy yielding substrates in patients with liver cirrhosis. Clin Invest. 1994;72:568–79. Mueller MJ, Boeker K, Selberg O. Metabolism of energy yielding substrates in patients with liver cirrhosis. Clin Invest. 1994;72:568–79.
14.
Zurück zum Zitat Owen OE, Trapp VE, Rechard GA, et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest. 1983;72:1821–32.PubMedCrossRef Owen OE, Trapp VE, Rechard GA, et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest. 1983;72:1821–32.PubMedCrossRef
15.
Zurück zum Zitat Verboeket-van de Venne WP, Weserterp KR, van Hoek B, Swart GR. Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: effects of the pattern of food intake. Gut. 1995;36:110–6.PubMedCrossRef Verboeket-van de Venne WP, Weserterp KR, van Hoek B, Swart GR. Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: effects of the pattern of food intake. Gut. 1995;36:110–6.PubMedCrossRef
16.
Zurück zum Zitat Imano E, Kanda T, Nakatani Y, et al. Impaired splanchnic and peripheral glucose uptake in liver cirrhosis. J Hepatol. 1999;31:469–73.PubMedCrossRef Imano E, Kanda T, Nakatani Y, et al. Impaired splanchnic and peripheral glucose uptake in liver cirrhosis. J Hepatol. 1999;31:469–73.PubMedCrossRef
17.
Zurück zum Zitat Kruszynska YT, Home PD, McIntyre N. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology. 1991;14:103–11.PubMedCrossRef Kruszynska YT, Home PD, McIntyre N. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology. 1991;14:103–11.PubMedCrossRef
18.
Zurück zum Zitat Shmueli E, Walker M, Alberti G, Record CO. Normal splanchnic but impaired peripheral insulin-stimulated glucose uptake in cirrhosis. Hepatology. 1993;18:86–95.PubMedCrossRef Shmueli E, Walker M, Alberti G, Record CO. Normal splanchnic but impaired peripheral insulin-stimulated glucose uptake in cirrhosis. Hepatology. 1993;18:86–95.PubMedCrossRef
19.
Zurück zum Zitat Leatherdale BA, Chase RA, Rogers J, Alberti KG, Davies P, Record CO. Forearm glucose uptake in cirrhosis and its relationship to glucose tolerance. Clin Sci. 1980;59:191–8.PubMed Leatherdale BA, Chase RA, Rogers J, Alberti KG, Davies P, Record CO. Forearm glucose uptake in cirrhosis and its relationship to glucose tolerance. Clin Sci. 1980;59:191–8.PubMed
20.
Zurück zum Zitat Selberg O, Burchert W, vd Hoff J, Meyer GJ, Hundeshagen H, Radoch E, et al. Insulin resistance in liver cirrhosis. J Clin Invest. 1993;91:1897–902.PubMedCrossRef Selberg O, Burchert W, vd Hoff J, Meyer GJ, Hundeshagen H, Radoch E, et al. Insulin resistance in liver cirrhosis. J Clin Invest. 1993;91:1897–902.PubMedCrossRef
Metadaten
Titel
Nonalcoholic fatty liver is a risk factor for postprandial hyperglycemia, but not for impaired fasting glucose
verfasst von
Tomoko Shiga
Yuriko Moriyoshi
Hikaru Nagahara
Keiko Shiratori
Publikationsdatum
01.07.2009
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 7/2009
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-009-0059-1

Weitere Artikel der Ausgabe 7/2009

Journal of Gastroenterology 7/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.